AventaMed DAC news

AventaMed will exhibit at the 2018 American Academy of Otolaryngologists (AAO) Annual Meeting & OTO Experience, October 7 – 10th in Atlanta, Georgia. Come say hello to us at booth 3326 and learn more about the Solo TTD. For more information or to schedule a meeting, contact john.vaughan@aventamed.com

In its 122nd year, the AAO-HNSF Annual Meeting & OTO Experience will feature all day cutting-edge education programming, and dynamic evening events drawing more than 5,500 o

AventaMed will exhibit at the 2019 American Academy of Otolaryngologists (AAO) Annual Meeting & OTO Experience, September 15th – 18th in New Orleans, LA. Come say hello to us at booth 432 in the Emerging Technologies Pavillion and learn more about the Solo TTD. For more information or to schedule a meeting, contact john.vaughan@aventamed.com

In its 123rd year, the AAO-HNSF Annual Meeting & OTO Experience will feature all day cutting-edge education programming, and dynami

CORK MEDTECH STARTUP AventaMed has joined a consortium of big-name healthcare companies for collaborations ahead of a planned US launch.

AventaMed has developed a device for inserting grommets into the eardrum, which prevents the build up of fluid.

The consortium – called the National Evaluation System for Health Technology Coordinating Center (NESTcc) – connects regulators and the industry to share and evaluate real-world evidence in the regulatory process for med

AventaMed, a Cork-based medical device start-up which is set to revolutionise paediatric ear, nose and throat surgery has beaten 26 global organizations in a major medical device bid.

The pioneering company will be one of 12 Real-World Evidence Test-Cases selected by The National Evaluation System for Health Technology Coordinating Center (NESTcc) to evaluate the use of real-world evidence (RWE) in medical device regulatory processes.

AventaMed is the first and only Irish comp

The National Evaluation System for health Technology Coordinating Center (NESTcc), an initiative of the Medical Device Innovation Consortium (MDIC), announces twelve new Test-Cases which leverage Real-World Evidence (RWE) and address key priorities for medical device stakeholders. These Test-Cases are intended to accelerate NESTcc’s progress and provide proof of concept for NESTcc’s ability to generate high-quality RWE for a range of medical devices through the